Patients’ Perception of Surgical Incisions Following Two Approaches for Total Hip Arthroplasty

Overview

About this study

Patients undergoing a total hip arthroplasty (THA) using either a direct anterior or posterolateral approach will be asked to return to clinic 2 years following THA to evaluate their scars from the incisions. Both the Patient Observer Scar Assessment Scale (POSAS) and the Stony Brook Scar Evaluation Scale (SBSES) will be used to assess patients’ scars. The results of these evaluation scales will then be compared between the anterior and posterolateral approach cohorts.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • Patients undergoing a total hip arthroplasty (THA) using either a direct anterior or posterolateral approach
  • 19 years of age or older
  • English-speaking, and ability to fill out a patient-reported outcome questionnaire

Exclusion criteria:

  • Any prior hip surgery
  • Simultaneous bilateral THA
  • Cemented THA
  • Bikini-incision direct anterior approaches
  • Any surgical treatment for scarring (i.e. scar revision surgery)
  • Previous superficial wound infection
  • Any hip revision surgery prior to the scar assessment date

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Michael Taunton, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions